Colchicine for Prevention of Recurrent Stroke—Are we CONVINCED?
Open Access
- 16 December 2025
- journal article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (24) , e044358
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Colchicine in Acute Myocardial InfarctionNew England Journal of Medicine, 2025
- The win ratio in cardiology trials: lessons learnt, new developments, and wise future useEuropean Heart Journal, 2024
- Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trialThe Lancet, 2024
- Colchicine and the heartEuropean Heart Journal, 2021
- Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trialsEuropean Heart Journal, 2021
- Colchicine in Patients with Chronic Coronary DiseaseNew England Journal of Medicine, 2020
- Efficacy and Safety of Low-Dose Colchicine after Myocardial InfarctionNew England Journal of Medicine, 2019
- Five-Year Risk of Stroke after TIA or Minor Ischemic StrokeNew England Journal of Medicine, 2018
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic DiseaseNew England Journal of Medicine, 2017
- Low-Dose Colchicine for Secondary Prevention of Cardiovascular DiseaseJACC, 2013